Meckler Jeffrey A
Insider CIK 1506916 · COCP CHIEF EXECUTIVE OFFICER, Director · TVTX Director · NTEC Chief Executive Officer, Director · INDP Co-Chief Executive Officer, Director, 10% owner · QLTI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-10 | 2026-09-11 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-10 | 2026-09-11 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 1,700 | $65.39 | $111.2K | 109,800 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-10 | 2026-09-11 | 10,000 | $17.44 | $174.4K | 101,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-10 | 2026-09-11 | 10,000 | $26.52 | $265.2K | 111,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 1,200 | $66.15 | $79.4K | 108,600 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 14,000 | $67.46 | $944.4K | 94,600 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 3,100 | $68.09 | $211.1K | 91,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-10 | 2026-09-11 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-10 | 2026-09-11 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 3,100 | $68.09 | $211.1K | 91,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 14,000 | $67.46 | $944.5K | 94,600 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 1,200 | $66.15 | $79.4K | 108,600 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-10 | 2026-09-11 | 1,700 | $65.39 | $111.2K | 109,800 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-10 | 2026-09-11 | 10,000 | $26.52 | $265.2K | 111,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-10 | 2026-09-11 | 10,000 | $17.44 | $174.4K | 101,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-05-19 | 2026-05-21 | 4,000 | — | $0 | 91,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-05-04 | 2026-05-06 | 8,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-05-04 | 2026-05-06 | 8,000 | $45.00 | $360.0K | 87,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-05-04 | 2026-05-06 | 8,000 | $16.33 | $130.6K | 95,500 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2026-02-11 | 2026-02-13 | 12,136 | — | $0 | 12,136 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2026-02-11 | 2026-02-13 | 12,136 | — | $0 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2026-02-11 | 2026-02-13 | 1,519 | — | $0 | 1,519 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2026-02-11 | 2026-02-13 | 1,519 | — | $0 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2026-02-11 | 2026-02-13 | 3,033 | — | $0 | 3,033 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2026-02-11 | 2026-02-13 | 3,033 | — | $0 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award | 2025-12-22 | 2025-12-29 | 216,617 | $2.03 | $439.7K | 229,929 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2025-07-27 | 2025-07-29 | 12,136 | $8.30 | $100.7K | 16,688 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award | 2025-07-27 | 2025-07-29 | 6,068 | $8.30 | $50.4K | 13,312 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-05-15 | 2025-05-16 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-05-15 | 2025-05-16 | 6,500 | — | $0 | 87,500 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 1,250 | $0.04 | $50 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 1,563 | $0.04 | $63 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 1,500 | $0.04 | $60 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 813 | $0.04 | $33 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 3,750 | $0.04 | $150 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | D To issuer deriv | 2025-04-10 | 2025-04-11 | 4,750 | $0.04 | $190 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2024-11-25 | 2024-11-26 | 42,553 | $1.18 | $50.2K | 42,553 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award | 2024-11-25 | 2024-11-26 | 42,553 | $1.18 | $50.2K | 202,859 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2024-10-09 | 2024-10-10 | 75,000 | — | $0 | 75,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2024-09-30 | 2024-09-30 | 40,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2024-09-30 | 2024-09-30 | 40,000 | $10.48 | $419.2K | 121,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-09-30 | 2024-09-30 | 40,000 | $14.06 | $562.4K | 81,000 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2024-08-08 | 2024-08-08 | 84,932 | $1.83 | $155.4K | 84,932 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award | 2024-08-08 | 2024-08-08 | 84,932 | $1.83 | $155.4K | 160,306 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-05-08 | 2024-05-10 | 6,500 | — | $0 | 81,000 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2024-01-22 | 2024-01-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-05-17 | 2023-05-19 | 13,500 | — | $0 | 13,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-05-17 | 2023-05-19 | 4,500 | — | $0 | 74,500 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2023-01-18 | 2023-01-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | P Buy | 2022-11-21 | 2022-11-22 | 9,600 | $1.90 | $18.2K | 75,374 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | P Buy | 2022-11-18 | 2022-11-22 | 400 | $1.76 | $704 | 65,774 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | P Buy | 2022-09-08 | 2022-09-12 | 10,308 | $2.80 | $28.9K | 65,374 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | P Buy | 2022-09-07 | 2022-09-08 | 8,632 | $2.57 | $22.2K | 55,066 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | P Buy | 2022-09-06 | 2022-09-08 | 1,060 | $2.44 | $2.6K | 46,434 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | P Buy | 2022-06-06 | 2022-06-07 | 19,727 | $2.63 | $51.9K | 45,374 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-05-11 | 2022-05-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-05-11 | 2022-05-12 | 3,000 | — | $0 | 70,000 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2022-01-26 | 2022-01-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | P Buy | 2021-11-18 | 2021-11-19 | 11,187 | $5.82 | $65.1K | 25,647 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | P Buy | 2021-09-14 | 2021-09-16 | 12,000 | $7.00 | $84.0K | 14,460 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | A Award deriv | 2021-08-04 | 2021-08-06 | 375,000 | — | $0 | 375,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-05-14 | 2021-05-18 | 3,000 | — | $0 | 67,000 | SEC↗ |
| NTEC Intec Pharma Ltd. | A Award deriv | 2020-07-15 | 2020-07-17 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 64,000 | SEC↗ |
| NTEC Intec Pharma Ltd. | P Buy | 2019-08-28 | 2019-08-29 | 20,000 | $0.68 | $13.6K | 196,761 | SEC↗ |
| NTEC Intec Pharma Ltd. | P Buy | 2019-08-23 | 2019-08-27 | 100,000 | $0.46 | $46.0K | 176,761 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 61,000 | SEC↗ |
| NTEC Intec Pharma Ltd. | A Award deriv | 2019-04-04 | 2019-04-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 59,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2017-05-17 | 2017-05-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2017-05-17 | 2017-05-18 | 2,500 | — | $0 | 56,500 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2016-06-17 | 2016-06-21 | 6,400 | — | $0 | 28,400 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2016-06-17 | 2016-06-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2016-05-18 | 2016-05-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2016-05-18 | 2016-05-19 | 2,000 | — | $0 | 54,000 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2016-03-15 | 2016-03-17 | 294,118 | $0.51 | $150.0K | 657,161 | SEC↗ |
| RTRX Retrophin, Inc. | P Buy | 2016-03-04 | 2016-03-07 | 5,000 | $15.31 | $76.5K | 52,000 | SEC↗ |
| RTRX Retrophin, Inc. | P Buy | 2016-03-03 | 2016-03-03 | 10,000 | $14.45 | $144.5K | 47,000 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2015-12-23 | 2015-12-28 | 100,000 | $0.58 | $58.0K | 363,043 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award deriv | 2015-10-01 | 2015-10-02 | 16,000,000 | — | $0 | 16,000,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-29 | 2015-07-01 | 12,500 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-29 | 2015-07-01 | 12,500 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-29 | 2015-07-01 | 12,500 | $3.30 | $41.3K | 107,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-29 | 2015-07-01 | 12,500 | $3.67 | $45.9K | 94,500 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2015-06-08 | 2015-06-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2015-06-08 | 2015-06-10 | 2,000 | — | $0 | 37,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-07 | 2015-06-09 | 6,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-07 | 2015-06-09 | 4,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-07 | 2015-06-09 | 6,000 | — | $0 | 82,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-07 | 2015-06-09 | 4,000 | — | $0 | 76,000 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2015-03-25 | 2015-03-27 | 163,043 | $0.92 | $150.0K | 263,043 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | A Award deriv | 2015-03-23 | 2015-03-25 | 1,750,000 | — | $0 | 1,750,000 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2014-12-18 | 2014-12-19 | 20,000 | $3.60 | $72.0K | 72,000 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2014-12-17 | 2014-12-19 | 6,000 | — | $0 | 6,000 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2014-12-17 | 2014-12-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2014-12-15 | 2014-12-17 | 2,000 | — | $0 | 4,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2014-12-15 | 2014-12-17 | 2,000 | — | $0 | 52,000 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2014-12-11 | 2014-12-15 | 25,000 | $0.45 | $11.3K | 25,000 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2014-12-11 | 2014-12-15 | 25,000 | $0.45 | $11.3K | 50,000 | SEC↗ |
| COCP Cocrystal Pharma, Inc. | P Buy | 2014-12-11 | 2014-12-15 | 50,000 | $0.46 | $23.0K | 100,000 | SEC↗ |
| RTRX Retrophin, Inc. | P Buy | 2014-11-25 | 2014-11-25 | 15,000 | $8.60 | $129.0K | 35,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2014-10-08 | 2014-10-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2014-10-08 | 2014-10-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-11-22 | 2013-11-25 | 225,000 | — | $0 | 225,000 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 6,000 | — | $0 | 6,000 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 11,000 | — | $0 | 11,000 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2013-06-28 | 2013-07-01 | 30,000 | $4.36 | $130.8K | 50,000 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2013-05-03 | 2013-05-06 | 20,000 | $7.96 | $159.2K | 20,000 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2012-07-10 | 2012-07-12 | 11,000 | — | $0 | 11,000 | SEC↗ |